NCT06755710

Brief Summary

The goal of this clinical study is to improve the outcome of outpatient PTSD treatment at two clinics treating majority ethnic Danes and refugees with PTSD respectively. The study will consist of two similar randomized controlled trials. The main questions the study aims to answer are:

  • Does an added motivation enhancement module as a precursor for PTSD treatment reduce dropout and increase treatment outcome?
  • Does an added Shared Decision-Making session which facilitate individualized treatment yield a superior outcome compared to PTSD treatment and PTSD treatment supplemented by motivation enhancement? Participants are recruited at two different clinics, Psychotherapeutic Unit (PU) and Competence Centre for Transcultural Psychiatry (CTP). At PU the participants are randomized to one of two arms, and at CTP to one of three arms. One arm is the control group where participants will receive treatment as usual (TAU), one arm is the first intervention group where the participants will receive an Introductory PTSD module consisting of four sessions focusing on enhancing motivation for PTSD treatment, before continuing in TAU. The last arm is the second intervention group, which will only take place at CTP. Here the patient will receive the Introductory PTSD module followed by a session of Shared Decision Making, where the participant together with the MD decides which of four standardized treatment courses they will receive. The treatment for all patients will last between 8-13 months.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
427

participants targeted

Target at P75+ for not_applicable

Timeline
29mo left

Started Jan 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress37%
Jan 2025Aug 2028

First Submitted

Initial submission to the registry

December 13, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

January 1, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

January 2, 2025

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 29, 2028

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2028

Last Updated

April 9, 2025

Status Verified

December 1, 2024

Enrollment Period

3.2 years

First QC Date

December 13, 2024

Last Update Submit

April 8, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • International Trauma Questionnaire (ITQ)

    A brief, simply worded measure, focusing only on the core features of PTSD and CPTSD, and employs straightforward diagnostic rules, based on the International Classification of Diseases, 11th edition (ICD-11). Scoring range: 0-4, lower scores reflect better outcome

    Change from baseline to end-of-treatment after approximately 10 months

Secondary Outcomes (13)

  • Readiness of Psychotherapy Index (RPI)

    Change from baseline to after intervention after approximately 1,5 months

  • Hopkins Symptom Check List-25 (HSCL)

    Change from baseline to end-of-treatment after approximately 10 months

  • Psychological Outcome Profiles questionnaire (PSYCHLOPS)

    Change from baseline to end-of-treatment after approximately 10 months

  • World Health Organisation - 5 Well-being Index (WHO-5)

    Change from baseline to end-of-treatment after approximately 10 months

  • Life Events Checklist for DSM-5 (LEC-5)

    Administered once at the initial assessment

  • +8 more secondary outcomes

Study Arms (3)

Treatment as usual (TAU)

ACTIVE COMPARATOR

8-12 months of treatment Interventions: Behavioral: treamtent as usuan (TAU)

Behavioral: Treatment as Usual

Introductory PTSD module + TAU

EXPERIMENTAL

9-13 months of treatment An intervention with an introductory PTSD module consistent of four sessions focusing on motivation followed by TAU

Behavioral: Introductory PTSD moduleBehavioral: Treatment as Usual

Introductory PTSD module + one session of Shared Decision Making + individualised treatment

EXPERIMENTAL

9-13 months of treatment Add-on introductory PTSD module and add-on patient-centred shared decision making session before continuing in the chosen standardised treatment.

Behavioral: Introductory PTSD moduleBehavioral: Shared Decision MakingBehavioral: Standardised treatments

Interventions

The Introductory PTSD module consist of four session focusing on motivation

Introductory PTSD module + TAUIntroductory PTSD module + one session of Shared Decision Making + individualised treatment

A patient-centred shared decision making session where one of four standardised treatments can be chosen

Introductory PTSD module + one session of Shared Decision Making + individualised treatment

Treatment as usual

Introductory PTSD module + TAUTreatment as usual (TAU)

One of four treatments Treatment as ususal Sessions with psychologists Sessions with nurses Sessions with medical doctors

Introductory PTSD module + one session of Shared Decision Making + individualised treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Adults (18 years or older)
  • PTSD pursuant to the ICD-10 research criteria
  • Signed informed consent
  • patients referred to "Main Level" treatment
  • Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F31.9). Participants are excluded only if the psychotic experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and/or depression.
  • Dependence syndrome of drugs or alcohol: Active dependence and use (F1x.24-F1x.26).
  • Adult (18 years or older)
  • Refugees or persons who have been family reunified with a refugee
  • PTSD pursuant to the ICD-10 research criteria
  • Psychological trauma experienced outside Denmark in the anamnesis. Trauma is imprisonment or detention with torture (according to the United Nations' definition of torture) or acts of cruel, inhuman and degrading treatment or punishment. Trauma can also be organised violence, long-term political persecution and harassment, or war and civil war experiences.
  • Signed informed consent
  • Severe psychotic disorder (defined as patients with an ICD-10 diagnosis F2x and F30.1-F31.9). Participants are excluded only if the psychotic experiences are assessed to be part of an independent psychotic disorder and not part of a severe PTSD and/or depression.
  • Dependence syndrome of drugs or alcohol: Active dependence and use (F1x.24-F1x.26).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mental Health Centre Ballerup

Ballerup Municipality, Capital Region, 2750, Denmark

RECRUITING

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticPatient Participation

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersPatient Acceptance of Health CareTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Jessica Carlsson

    Mental Health Services in th Capital Region, Denmark

    STUDY CHAIR

Central Study Contacts

Anna Bolette L. Nielsen, Medical Doctor

CONTACT

Laura E. Fonnesbaek, Authorised psychologist

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

December 13, 2024

First Posted

January 1, 2025

Study Start

January 2, 2025

Primary Completion (Estimated)

February 29, 2028

Study Completion (Estimated)

August 31, 2028

Last Updated

April 9, 2025

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations